scholarly journals Brigatinib (BRG) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC): Long-term efficacy and safety results from a phase 1/2 trial

2017 ◽  
Vol 28 ◽  
pp. v479-v480 ◽  
Author(s):  
L.A. Bazhenova ◽  
S.N. Gettinger ◽  
C.J. Langer ◽  
R. Salgia ◽  
K.A. Gold ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Phase 1 ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma ◽  
Alk Positive

scholarly journals Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

2018 ◽  
Vol Volume 10 ◽  
pp. 6555-6561 ◽  
Author(s):  
Ahmed Mohieldin ◽  
Ayman Rasmy ◽  
Mohamed Ashour ◽  
Muath Al-Nassar ◽  
Rola H Ali ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Small Cell ◽  
Advanced Stage ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma
Sign in / Sign up

Export Citation Format

Share Document